FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3085957763> ?p ?o ?g. }

• W3085957763 endingPage "196" @default.
• W3085957763 startingPage "188" @default.
• W3085957763 abstract "Purpose: The current study aims to evaluate the in vitro cytotoxic and cell migration effects of synthetic curcumin and its analogues on HER2 and nuclear factor kappa B (NFκB) pathways, as well as the in vivo inhibitory effect on cancer growth of metastatic breast cancer. Methods: Cell viability, protein expression, and protein localization were determined in vitro using MTT assay, western blotting, and immunofluorescence, respectively. Meanwhile, scratch wound healing assay and gelatin zymography were conducted to investigate the metastasis inhibitory effect. The in vivo anti-tumor ability was evaluated in xenograft mouse model using triple-negative breast cancer (TNBC) cells. Results: Curcumin, PGV-0, and PGV-1 exhibited cytotoxic effect against HER2-overexpressing breast cancer cells. Although PGV-1 showed the best activity in the single cytotoxic assay, curcumin showed the strongest synergism with doxorubicin. Curcumin and PGV-0 inhibited membrane localization of HER2. In contrast, PGV-1 neither inhibited localization nor decreased the expression of HER2, nonetheless showed the most potent inhibition against nuclear localization of p65 indicating the different mechanisms of curcumin, PGV-0, and PGV-1. Regarding cancer metastasis, curcumin and PGV-1 showed inhibitory activities against cell migration and inhibited MMP-2 and MMP-9 protein expression. Lastly, PGV-1 was more potent compared to curcumin to suppress the tumor formation of metastatic breast cancer xenograft model in nude mice. Conclusion: Overall, our study strengthens the potency of curcumin analogue, PGV-1, for treating several types of cancer, including metastatic breast cancer." @default.
• W3085957763 created "2020-09-21" @default.
• W3085957763 creator A5010786794 @default.
• W3085957763 creator A5016716688 @default.
• W3085957763 creator A5024800366 @default.
• W3085957763 creator A5027397009 @default.
• W3085957763 creator A5029415260 @default.
• W3085957763 creator A5037955020 @default.
• W3085957763 creator A5039441923 @default.
• W3085957763 creator A5040556090 @default.
• W3085957763 creator A5049142320 @default.
• W3085957763 creator A5071211913 @default.
• W3085957763 creator A5074828944 @default.
• W3085957763 creator A5080822378 @default.
• W3085957763 date "2020-11-07" @default.
• W3085957763 modified "2023-10-01" @default.
• W3085957763 title "The Target Differences of Anti-Tumorigenesis Potential of Curcumin and its Analogues Against HER-2 Positive and Triple-Negative Breast Cancer Cells" @default.
• W3085957763 cites W1551407310 @default.
• W3085957763 cites W1581923494 @default.
• W3085957763 cites W166196450 @default.
• W3085957763 cites W1921951626 @default.
• W3085957763 cites W1951105808 @default.
• W3085957763 cites W1964770292 @default.
• W3085957763 cites W1984795762 @default.
• W3085957763 cites W1994296373 @default.
• W3085957763 cites W2013329576 @default.
• W3085957763 cites W2041764058 @default.
• W3085957763 cites W2075023965 @default.
• W3085957763 cites W2078454159 @default.
• W3085957763 cites W2085628509 @default.
• W3085957763 cites W2086605103 @default.
• W3085957763 cites W2090229207 @default.
• W3085957763 cites W2096901612 @default.
• W3085957763 cites W2106413201 @default.
• W3085957763 cites W2125598794 @default.
• W3085957763 cites W2136891928 @default.
• W3085957763 cites W2289834888 @default.
• W3085957763 cites W2291119224 @default.
• W3085957763 cites W2411104574 @default.
• W3085957763 cites W2416143383 @default.
• W3085957763 cites W2541366324 @default.
• W3085957763 cites W2563155404 @default.
• W3085957763 cites W2781880721 @default.
• W3085957763 cites W2802030122 @default.
• W3085957763 cites W2912285426 @default.
• W3085957763 cites W2965510556 @default.
• W3085957763 cites W2980922005 @default.
• W3085957763 cites W2986179979 @default.
• W3085957763 doi "https://doi.org/10.34172/apb.2021.020" @default.
• W3085957763 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7961225" @default.
• W3085957763 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33747866" @default.
• W3085957763 hasPublicationYear "2020" @default.
• W3085957763 type Work @default.
• W3085957763 sameAs 3085957763 @default.
• W3085957763 citedByCount "12" @default.
• W3085957763 countsByYear W30859577632021 @default.
• W3085957763 countsByYear W30859577632022 @default.
• W3085957763 countsByYear W30859577632023 @default.
• W3085957763 crossrefType "journal-article" @default.
• W3085957763 hasAuthorship W3085957763A5010786794 @default.
• W3085957763 hasAuthorship W3085957763A5016716688 @default.
• W3085957763 hasAuthorship W3085957763A5024800366 @default.
• W3085957763 hasAuthorship W3085957763A5027397009 @default.
• W3085957763 hasAuthorship W3085957763A5029415260 @default.
• W3085957763 hasAuthorship W3085957763A5037955020 @default.
• W3085957763 hasAuthorship W3085957763A5039441923 @default.
• W3085957763 hasAuthorship W3085957763A5040556090 @default.
• W3085957763 hasAuthorship W3085957763A5049142320 @default.
• W3085957763 hasAuthorship W3085957763A5071211913 @default.
• W3085957763 hasAuthorship W3085957763A5074828944 @default.
• W3085957763 hasAuthorship W3085957763A5080822378 @default.
• W3085957763 hasBestOaLocation W30859577632 @default.
• W3085957763 hasConcept C121608353 @default.
• W3085957763 hasConcept C126322002 @default.
• W3085957763 hasConcept C143998085 @default.
• W3085957763 hasConcept C2778250585 @default.
• W3085957763 hasConcept C2780110267 @default.
• W3085957763 hasConcept C2992734768 @default.
• W3085957763 hasConcept C502942594 @default.
• W3085957763 hasConcept C530470458 @default.
• W3085957763 hasConcept C555283112 @default.
• W3085957763 hasConcept C71924100 @default.
• W3085957763 hasConcept C98274493 @default.
• W3085957763 hasConceptScore W3085957763C121608353 @default.
• W3085957763 hasConceptScore W3085957763C126322002 @default.
• W3085957763 hasConceptScore W3085957763C143998085 @default.
• W3085957763 hasConceptScore W3085957763C2778250585 @default.
• W3085957763 hasConceptScore W3085957763C2780110267 @default.
• W3085957763 hasConceptScore W3085957763C2992734768 @default.
• W3085957763 hasConceptScore W3085957763C502942594 @default.
• W3085957763 hasConceptScore W3085957763C530470458 @default.
• W3085957763 hasConceptScore W3085957763C555283112 @default.
• W3085957763 hasConceptScore W3085957763C71924100 @default.
• W3085957763 hasConceptScore W3085957763C98274493 @default.
• W3085957763 hasIssue "1" @default.
• W3085957763 hasLocation W30859577631 @default.
• W3085957763 hasLocation W30859577632 @default.
• W3085957763 hasOpenAccess W3085957763 @default.

• next